Madrigal Pharmaceuticals (YDO1.XETRA) Q2 2026 Earnings

6MayConfirmed
Q2 2026
-3.6
-3.32
-3.04
-2.77

Details

Expected EPS
-3.599421087
Actual EPS
-2.7657499999999997
Surprise EPS
0.83
Surprise Percent
+23.16%

Description

Madrigal Pharmaceuticals (YDO1.XETRA) has reported earnings of -2.7657499999999997 per share for Q2 2026.

0 Comments

Share your thoughts